Yunman Li

Dr. Yunman Li

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2020 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
BLBinbin Li
Binbin Li
LHLiangliang Huang
Liangliang Huang
PLPeng Lv
Peng Lv
XLXiang Li
Xiang Li
GLGe Liu
Ge Liu
WFWeirong Fang
Weirong Fang

1 July 2017 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
YFYu-Xiang Fei
Yu-Xiang Fei
SWSi-Qi Wang
Si-Qi Wang
LYLi-Jian Yang
Li-Jian Yang
YQYan-Ying Qiu
Yan-Ying Qiu
YLYi-Ze Li
Yi-Ze Li
YLYunman Li
Yunman Li

1 March 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XLXiang Li
Xiang Li
LHLiangliang Huang
Liangliang Huang
GLGe Liu
Ge Liu
WFWenxiang Fan
Wenxiang Fan
BLBinbin Li
Binbin Li
WFWeirong Fang
Weirong Fang

1 May 2019 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
KHKai Hou
Kai Hou
DXDan Xu
Dan Xu
FLFengyang Li
Fengyang Li
SCShijie Chen
Shijie Chen
YLYunman Li
Yunman Li

4 May 2021 in Journal of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
XGXue Gou
Xue Gou
DXDan Xu
Dan Xu
FLFengyang Li
Fengyang Li
KHKai Hou
Kai Hou
WFWeirong Fang
Weirong Fang
YLYunman Li
Yunman Li

1 October 2022 in Aging and disease
Verified
Journal Article
Open access
LHLiangliang Huang
Liangliang Huang
YCYan Chen
Yan Chen
RLRui Liu
Rui Liu
BLBinbin Li
Binbin Li
XFXuan Fei
Xuan Fei
WFWeirong Fang
Weirong Fang
P-glycoprotein (P-gp) is expressed on brain microvessel endothelial cells of blood-brain barrier (BBB) and elevated after cerebral ischemia. In this study, we explored the influence and potential mechanisms of P-gp on BBB function in experimental ischemic stroke in vivo and in vitro. Middle cerebral artery occlusion/reperfusion (MCAO/R) was created in mice. Oxygen-glucose deprivation/reoxygenation (OGD/R) was performed in brain microvascular vessel-derived endothelial cells (bEnd.3) to mimic ischemia/reperfusion injury in vitro. P-gp-specific siRNA and pharmacological inhibitor cyclosporine A were used to inhibit P-gp, whereas pcDNA3.1 was utilized to overexpress P-gp. Twenty-four hours after reperfusion, acute ischemic stroke outcome, BBB integrity and permeability, autophagic proteins and relative signaling pathways were evaluated. P-gp levels were markedly elevated in mouse brain and endothelial cells following MCAO/R and OGD/R, respectively. P-gp siRNA silencing or pharmacologically inhibiting (cyclosporine A) reduced infarct volume and brain edema, attenuated brain pathology, and improved neurological behavior in association with attenuated accumulation of neutrophils and macrophages, reduced expression levels of inflammatory cytokines (TNF-α and IL-1β), matrix metalloproteinases (MMP-2 and MMP-9) and adhesion molecules (ICAM-1 and VCAM-1). P-gp silence also counteracted BBB leakage, restored the expressions of tight junction proteins (Claudin-5, Occludin and ZO-1), activated autophagic proteins (upregulated LC3-II/LC3-I and Beclin 1, and downregulated P62), and diminished Akt/mTOR signal activity in mice following MCAO/R. In the endothelial cell OGD/R assay, P-gp silence downregulated the expressions of inflammatory cytokines and adhesion molecules, inhibited leukocytes adhesion and migration, increased tight junction protein levels, and activated autophagy, all were reversible by forceful P-gp expression. Additionally, treatment with an autophagy inhibitor (3-methyladenine) abolished protections against ischemic stroke and tight junction proteins reduction followed by P-gp silence. In conclusion, increased P-gp expression after ischemic injury resulted in BBB dysfunction and hyperpermeability by suppressing Akt/mTOR-induced endothelial autophagy.